Form D · Biotechnology
Stealth BioTherapeutics Corp
Grand Cayman, E9 · CIK 0001696396
Offering snapshot reported Apr 13, 2020 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 10, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2020 | Initial | $20,000,001 | No comparison | 1 | SEC filing |
| Oct 15, 2019 | Initial | $14,999,999 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-364841
Source: Form D, filed Apr 13, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gerald Chan | Director |
| Francis Chen | Director |
| Lu Huang | Director |
| Lou Lange | Director |
| Irene Mc Carthy | Director, Executive |
| Kevin Mc Laughlin | Director |
| Edward Owens | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
190 Elgin Avenue George Town
Grand Cayman, E9, KY1-9005
Grand Cayman, E9, KY1-9005